ACQUISITION OF BENEFICIAL OWNERSHIP

Company

Taysha Gene Therapies, Inc.

Filed

October 5, 2020

Accession Number

0001387131-20-008773

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →